NANOMEDICINE

Phage-boosted chemotherapy

Drug-loaded nanoparticles that specifically bind to phages infecting cancer-promoting bacteria found in colonic tumours augment the effects of chemotherapy against colorectal cancer in mice.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Fig. 1: Phage-targeted microbiota-modulating nanomedicine for treating colorectal cancer in mice.

References

  1. 1.

    Arnold, M. et al. Gut 66, 683 (2017).

  2. 2.

    Carding, S. et al. Microb. Ecol. Health Dis. 26, 26191–26191 (2015).

  3. 3.

    Bridges, K. M. et al. Curr. Colorectal Cancer Rep. 15, 70–77 (2019).

  4. 4.

    Tilg, H. et al. Cancer Cell 33, 954–964 (2018).

  5. 5.

    Schwabe, R. F. & Jobin, C. Nat. Rev. Cancer 13, 800–812 (2013).

  6. 6.

    Liang, Q. et al. Clin. Cancer Res. 23, 2061 (2017).

  7. 7.

    Dos Reis, S. A. et al. Nutr. Res. 37, 1–19 (2017).

  8. 8.

    Bullman, S. et al. Science 358, 1443 (2017).

  9. 9.

    Zheng, D.-W. et al. Nat. Biomed. Eng. https://doi.org/10.1038/s41551-019-0423-2 (2019).

  10. 10.

    Heymann, D. Curr Opin Investig Drugs 7, 443–450 (2006).

  11. 11.

    Ursell, L. K. et al. J Allergy Clin Immunol 129, 1204–1208 (2012).

  12. 12.

    Mima, K. et al. Gut 65, 1973 (2016).

  13. 13.

    Nicholson, J. K. et al. Science 336, 1262 (2012).

Download references

Author information

Correspondence to Matthew Wook Chang.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Aggarwal, N., Hwang, I.Y. & Chang, M.W. Phage-boosted chemotherapy. Nat Biomed Eng 3, 680–681 (2019). https://doi.org/10.1038/s41551-019-0450-z

Download citation